Showing results (171-180 of 209) with videos related to
Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102Lavakumar Karyampudi, Courtney Formicola, Courtney L Erskine, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 21, 2002
Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological TherapyUlrich Keilholz, Jeffrey Weber, James H Finke, et al.Cancer Immunology, Immunotherapy : CII|July 22, 2009
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigenLavakumar Karyampudi, Christopher J Krco, Kimberly R Kalli, et al.Journal of the National Cancer Institute|September 11, 2019
Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast CancerJohannes F Fahrmann, Jody Vykoukal, Alia Fleury, et al.Journal for Immunotherapy of Cancer|May 19, 2017
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapySacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, et al.JAMA Oncology|January 25, 2019
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor TrialMary L Disis, Matthew H Taylor, Karen Kelly, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activationLeisha A Emens, Justin M Asquith, James M Leatherman, et al.Journal for Immunotherapy of Cancer|March 28, 2025
SITC strategic vision: prevention, premalignant immunity, host and environmental factorsSasha E Stanton, Kristin G Anderson, Tullia C Bruno, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2017
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid TumorsJeffrey S Miller, Chihiro Morishima, Douglas G McNeel, et al.NPJ Breast Cancer|November 9, 2019
If we build it they will come: targeting the immune response to breast cancerMargaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, et al.Pageof 21